eISSN: 3023-6940
Home
Aim&Scope
Archive
Journal Archive
Last Issue
Most Read Articles
Most Cited Articles
Index Authors
About
About The Journal
Editorial Board
Indexed By
Instructions for Authors
Author Guidelines
Forms
Peer Review Process
E-Submission
Publication Policies
Publication Ethics
Conflicts of Interest and Financial Disclosures
Copright&Licensing
Open Access&Deposit Policy
Plagiarism
Artificial Intelligence Policy
Pricing Policy
Ethical Responsibilities of Reviewers
Authorship Responsibilities
Editorial Board Responsibilities
Contact
Home
Aim&Scope
Archive
Journal Archive
Last Issue
Most Read Articles
Most Cited Articles
Index Authors
About
About The Journal
Editorial Board
Indexed By
Instructions for Authors
Author Guidelines
Forms
Peer Review Process
E-Submission
Publication Policies
Publication Ethics
Conflicts of Interest and Financial Disclosures
Copright&Licensing
Open Access&Deposit Policy
Plagiarism
Artificial Intelligence Policy
Pricing Policy
Ethical Responsibilities of Reviewers
Authorship Responsibilities
Editorial Board Responsibilities
Contact
×
Home
The rate of use of phosphodiesterase-5 (PDE5) inhibitor without physician recommendation and the faults of using medication in patients with erectile dysfunction
Article Tools
Download PDF
Full Text
How to Cite
Share
Twitter
Facebook
Linkedin
How to Cite
×
Data not found.
Related Subjects
E-SUBMISSION
Current Issue
Accepted Articles
Archive
Covers
Most Read Articles
Patient Consent Form
Copyright Agreement
ICMJE Disclosure of Interest
Original Article
The rate of use of phosphodiesterase-5 (PDE5) inhibitor without physician recommendation and the faults of using medication in patients with erectile dysfunction
Erdal Benli
İD
1-
Orhan Koca
İD
1-
İlhan Geçit
İD
2-
Affiliations
Pendik Hospital Üroloji Kliniği, Pendik-İstanbul
DOI :
New J Urol. 2011; 6 (2): 26-31
Creative Commons
LİMRA
DIGITAL